Other OTC - Delayed Quote • USD
Item 9 Labs Corp. (INLB)
At close: May 13 at 9:30 AM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Robert E. Mikkelsen | Secretary, Treasurer & CFO | 263.68k | -- | 1982 |
Mr. Christopher Leland Wolven | Chief Operating Officer | 256.45k | -- | 1983 |
Mr. Jeffrey I. Rassas | Strategic Advisor & Director | 176.58k | -- | 1963 |
Ms. Jayne Levy | Senior Vice President of Communications | -- | -- | -- |
Kyle Jennings | Vice President of Marketing | -- | -- | -- |
Mr. Mark Busch | Senior Vice President of Corporate Development | -- | -- | -- |
Mr. Cory Carter | Senior Vice President of Cultivation | -- | -- | -- |
Item 9 Labs Corp.
2727 North 3rd Street
Suite 201
Phoenix, AZ 85004
United States
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 97
Description
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Corporate Governance
Item 9 Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Aug 21, 202310-Q: Periodic Financial ReportsSee Full Filing
- Jul 20, 20238-K: Corporate Changes & Voting MattersSee Full Filing
- Jul 07, 20238-K: Corporate Changes & Voting MattersSee Full Filing
- Jun 27, 20238-K: Corporate Changes & Voting MattersSee Full Filing
- Jun 06, 20238-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
May 20, 2024 - May 24, 2024
Item 9 Labs Corp. Earnings Call
Related Tickers
LTTSF Lotus Ventures Inc.
0.0051
0.00%
OWPC One World Products, Inc.
0.0586
-0.61%
DVLP Golden Developing Solutions, Inc.
0.0001
0.00%
MCUJF Medicure Inc.
0.7900
0.00%
OASMY Vivesto AB
0.0499
0.00%
HKMPY Hikma Pharmaceuticals PLC
50.08
0.00%
KALY Kali, Inc.
0.0000
0.00%
CANB Can B Corp.
0.0258
-9.47%
GBHPF Global Hemp Group Inc.
0.0600
0.00%
NWPN The Now Corporation
0.0001
0.00%